Luteinizing Hormone/Choriogonadotropin Receptor (LHCGR) (C-Term) Peptid
LHCGR
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle LHCGR Produkte
- LHCGR (Luteinizing Hormone/Choriogonadotropin Receptor (LHCGR))
- Protein Region
- C-Term
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Sequenz
- LLLSKFGCCK RRAELYRRKD FSAYTSNCKN GFTGSNKPSQ STLKLSTLHC
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-LHCGR Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- LHCGR (Luteinizing Hormone/Choriogonadotropin Receptor (LHCGR))
- Hintergrund
-
This gene encodes the receptor for both luteinizing hormone and choriogonadotropin. This receptor belongs to the G-protein coupled receptor 1 family, and its activity is mediated by G proteins which activate adenylate cyclase. Mutations in this gene result in disorders of male secondary sexual character development, including familial male precocious puberty, also known as testotoxicosis, hypogonadotropic hypogonadism, Leydig cell adenoma with precocious puberty, and male pseudohermaphtoditism with Leydig cell hypoplasia.
Protein Size: 636 - Gen-ID
- 3973
-
Sie sind hier:
